241 related articles for article (PubMed ID: 23031199)
21. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
Chen W; Huang Q; Ma S; Li M
ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
[TBL] [Abstract][Full Text] [Related]
22. Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts.
Wenker SD; Leal MC; Farías MI; Zeng X; Pitossi FJ
Brain Res; 2016 May; 1638(Pt A):15-29. PubMed ID: 26239914
[TBL] [Abstract][Full Text] [Related]
23. Secretome of Undifferentiated Neural Progenitor Cells Induces Histological and Motor Improvements in a Rat Model of Parkinson's Disease.
Mendes-Pinheiro B; Teixeira FG; Anjo SI; Manadas B; Behie LA; Salgado AJ
Stem Cells Transl Med; 2018 Nov; 7(11):829-838. PubMed ID: 30238668
[TBL] [Abstract][Full Text] [Related]
24. The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson's disease model.
Cai J; Donaldson A; Yang M; German MS; Enikolopov G; Iacovitti L
Stem Cells; 2009 Jan; 27(1):220-9. PubMed ID: 18832589
[TBL] [Abstract][Full Text] [Related]
25. Bioluminescence-driven optogenetic activation of transplanted neural precursor cells improves motor deficits in a Parkinson's disease mouse model.
Zenchak JR; Palmateer B; Dorka N; Brown TM; Wagner LM; Medendorp WE; Petersen ED; Prakash M; Hochgeschwender U
J Neurosci Res; 2020 Mar; 98(3):458-468. PubMed ID: 29577367
[TBL] [Abstract][Full Text] [Related]
26. Lmx1a enhances the effect of iNSCs in a PD model.
Wu J; Sheng C; Liu Z; Jia W; Wang B; Li M; Fu L; Ren Z; An J; Sang L; Song G; Wu Y; Xu Y; Wang S; Chen Z; Zhou Q; Zhang YA
Stem Cell Res; 2015 Jan; 14(1):1-9. PubMed ID: 25460246
[TBL] [Abstract][Full Text] [Related]
27. Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson's disease model.
Yuan Y; Tang X; Bai YF; Wang S; An J; Wu Y; Xu ZD; Zhang YA; Chen Z
Theranostics; 2018; 8(17):4679-4694. PubMed ID: 30279731
[TBL] [Abstract][Full Text] [Related]
28. Treatment of Parkinson's disease model mice with allogeneic embryonic stem cells: necessity of immunosuppressive treatment for sustained improvement.
Toriumi H; Yoshikawa M; Matsuda R; Nishimura F; Yamada S; Hirabayashi H; Nakase H; Nonaka J; Ouji Y; Ishizaka S; Sakaki T
Neurol Res; 2009 Apr; 31(3):220-7. PubMed ID: 19406036
[TBL] [Abstract][Full Text] [Related]
29. Early Expression of Neuronal Dopaminergic Markers in a Parkinson's Disease Model in Rats Implanted with Enteric Stem Cells (ENSCs).
Parra-Cid C; Orozco-Castillo E; García-López J; Contreras-Figueroa E; Ramos-Languren LE; Ibarra C; Carreón-Rodríguez A; Aschner M; Königsberg M; Santamaría A
CNS Neurol Disord Drug Targets; 2020; 19(2):148-162. PubMed ID: 32303175
[TBL] [Abstract][Full Text] [Related]
30. Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice.
Hwang DY; Ardayfio P; Kang UJ; Semina EV; Kim KS
Brain Res Mol Brain Res; 2003 Jun; 114(2):123-31. PubMed ID: 12829322
[TBL] [Abstract][Full Text] [Related]
31. Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease.
Han F; Wang W; Chen B; Chen C; Li S; Lu X; Duan J; Zhang Y; Zhang YA; Guo W; Li G
Cytotherapy; 2015 May; 17(5):665-79. PubMed ID: 25747741
[TBL] [Abstract][Full Text] [Related]
32. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
[TBL] [Abstract][Full Text] [Related]
33. Promotive effects of tetrahydroxystilbene glucoside on the differentiation of neural stem cells from the mesencephalon into dopaminergic neurons.
Zhang L; Yang H
Neurosci Lett; 2021 Jan; 742():135520. PubMed ID: 33246026
[TBL] [Abstract][Full Text] [Related]
34. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
[TBL] [Abstract][Full Text] [Related]
35. Combined MSC-Secreted Factors and Neural Stem Cell Transplantation Promote Functional Recovery of PD Rats.
Yao Y; Huang C; Gu P; Wen T
Cell Transplant; 2016; 25(6):1101-13. PubMed ID: 26607204
[TBL] [Abstract][Full Text] [Related]
36. Distinct efficacy of pre-differentiated versus intact fetal mesencephalon-derived human neural progenitor cells in alleviating rat model of Parkinson's disease.
Wang X; Lu Y; Zhang H; Wang K; He Q; Wang Y; Liu X; Li L; Wang X
Int J Dev Neurosci; 2004 Jun; 22(4):175-83. PubMed ID: 15245752
[TBL] [Abstract][Full Text] [Related]
37. Dopaminergic-like neurons derived from oral mucosa stem cells by developmental cues improve symptoms in the hemi-parkinsonian rat model.
Ganz J; Arie I; Buch S; Zur TB; Barhum Y; Pour S; Araidy S; Pitaru S; Offen D
PLoS One; 2014; 9(6):e100445. PubMed ID: 24945922
[TBL] [Abstract][Full Text] [Related]
38. Chemical Control of Grafted Human PSC-Derived Neurons in a Mouse Model of Parkinson's Disease.
Chen Y; Xiong M; Dong Y; Haberman A; Cao J; Liu H; Zhou W; Zhang SC
Cell Stem Cell; 2016 Jun; 18(6):817-826. PubMed ID: 27133795
[TBL] [Abstract][Full Text] [Related]
39. Reducing glypican-4 in ES cells improves recovery in a rat model of Parkinson's disease by increasing the production of dopaminergic neurons and decreasing teratoma formation.
Fico A; de Chevigny A; Melon C; Bohic M; Kerkerian-Le Goff L; Maina F; Dono R; Cremer H
J Neurosci; 2014 Jun; 34(24):8318-23. PubMed ID: 24920634
[TBL] [Abstract][Full Text] [Related]
40. Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's disease.
Offen D; Barhum Y; Levy YS; Burshtein A; Panet H; Cherlow T; Melamed E
J Neural Transm Suppl; 2007; (72):133-43. PubMed ID: 17982886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
